Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (unaudited)

v3.10.0.1
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (14,053,024) $ (10,183,614)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,187,319 478,495
Share-based compensation 3,266,679 2,076,829
Amortization of debt discount 770,835
Change in fair value of derivative liabilities (186,701)
Change in fair value of contingent real estate liability 100,445 79,305
Changes in operating assets and liabilities:    
Accounts receivable (97,964) (298,797)
Inventory (49,291) 113,497
Prepaid expenses (31,291) (23,850)
Other current asset (60,552) 259
Other assets (125,001) (22,146)
Accounts payable and accrued expenses 737,246 982,729
Change in other long-term liabilities 12,500
Deferred revenue (28,516) 62,947
Net Cash Used In Operating Activities (8,557,316) (6,734,346)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Cash paid for machinery and equipment (1,749,249) (4,471,121)
Cash received from sale of assets held for sale 33,250
Cash paid for intangibles (56,681) (33,250)
Net Cash Used In Investing Activities (1,772,680) (4,504,371)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from the issuance of common stock 28,659,168 13,258,063
Proceeds from exercise of warrants 70,520 47,665
Proceeds received from convertible notes, net 8,867,272  
Net Cash Provided By Financing Activities 37,596,960 13,305,728
Net Increase (Decrease) in Cash 27,266,964 2,067,011
Cash - Beginning of Period 14,816,717 9,631,520
Cash - End of Period 42,083,681 11,698,531
Cash Paid During the Period for:    
Income taxes
Interest 199
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Accrued interest paid in common shares 533,539
ASC 606 transition adjustment 20,416
Warrants issued for stock issuance costs 645,757
Convertible Notes - Beneficial Conversion Feature 3,950,839
Accrued capital expenditures $ 428,691